-+ 0.00%
-+ 0.00%
-+ 0.00%

Jefferies Downgrades PTC Therapeutics to Hold, Lowers Price Target to $76

Benzinga·03/30/2026 15:57:42
Listen to the news
Jefferies analyst Faisal Khurshid downgrades PTC Therapeutics (NASDAQ:PTCT) from Buy to Hold and lowers the price target from $91 to $76.